Section Arrow
Quote
BBOT.NASDAQ
- BridgeBio Oncology Therapeutics Inc
Quotes are at least 15-min delayed:2026/07/19 09:27 EDT
Regular Hours
Last
 8.56
+0.25 (+3.01%)
Day High 
8.61 
Prev. Close
8.31 
1-M High
9.46 
Volume 
269.66K 
Bid
8.57
Ask
8.88
Day Low
7.935 
Open
8.26 
1-M Low
7.29 
Market Cap 
665.69M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.53 
20-SMA 8.08 
50-SMA 8.14 
52-W High 14.87 
52-W Low 7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.92/-2.35
Enterprise Value
667.93M
Balance Sheet
Book Value Per Share
4.65
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ATAIAtaiBeckley Inc7.22+0.07+0.98%-- 
JSPRJasper Therapeutics0.885+0.111+14.34%-- 
LIMNLiminatus Pharma Inc0.123-0.0247-16.72%-- 
IOVAIovance Biotherapeutics5+0.34+7.30%-- 
RXRXRecursion Pharmaceuticals2.945-0.075-2.48%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.